Therapeutic Category of Drugs in Japan

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level 

     ATC
 1  Agents affecting nervous system and sensory organs
 
 2  Agents affecting individual organs
 
 3  Agents affecting metabolism
 
 4  Agents affecting cellular function
   41  Cellular function activating agents
   42  Antineoplastics
     421  Alkylating agents
     422  Antimetabolites
       4221  Mercaptopurines
       4222  Methotrexates
       4223  Fluorouracils
       4224  Cytosines
       4229  Others
         D06503  Pemetrexed sodium hydrate (JAN)
         D05589  Pralatrexate (JAN/USAN/INN)
         D01907  Fludarabine phosphate (JAN/USP)
         D03546  Clofarabine (JAN/USAN/INN)
         D05134  Nelarabine (JAN/USAN/INN); Nelzarabine (USAN)
         D02131  Tegafur and uracil
         D06399  Tegafur, gimeracil and oteracil potassium
         D00341  Hydroxyurea (USP); Hydroxycarbamide (JAN/INN)
L01BA04
L01BA05
L01BB05
L01BB06
L01BB07
L01BC53
L01BC53
L01XX05
     423  Antibiotics
     424  Plant extract preparations
     429  Miscellaneous
   43  Radioactive drugs
   44  Allergic agents
   49  Other agents affecting cellular function
 
 5  Crude drugs and Chinese medicine formulations
 
 6  Agents against pathologic organisms and parasites
 
 7  Agents not mainly for therapeutic purpose
 
 8  Narcotics

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: July 3, 2019
Classification code 87 in the Japan Standard Commodity Classification

» Japanese version